ATLASCRISPR Therapeutics AG (CRSP) earnings date: Nov 9, 2026
CRISPR Therapeutics AG (CRSP) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 9, 2026, after the close. Analysts expect EPS of -$1.06.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on CRSP
| Last price | $51.42 (-5.2%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.2% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the CRISPR Therapeutics AG stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
CRISPR Therapeutics AG reports on Nov 9, 2026. One email the day before, with ATLAS’s read on CRISPR Therapeutics AG. You can switch it off at any time.
Alert me before CRSP reportsFree to start. Creating an account takes under a minute.
CRSP earnings at a glance
| Next report (confirmed) | Mon, Nov 9, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$1.06 |
| Last report | Jul 28, 2026 · Beat |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | +34.2% |
| Average move around a report | ±3.6% (last 4) |
| Sector | Healthcare · Biotechnology |
CRISPR Therapeutics AG earnings history: last 4 reports
CRISPR Therapeutics AG last reported on Jul 28, 2026: EPS of $0.89 against an estimate of $0.87 (+2.3% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Jul 28, 2026 | $0.87 | $0.89 | +2.3% | Beat | +2.0% |
| May 4, 2026 | -$1.23 | -$1.28 | -4.1% | Miss | +1.5% |
| Mar 4, 2026 | $0.06 | $0.15 | +150.0% | Beat | -1.3% |
| Feb 12, 2026 | -$1.23 | -$1.37 | -11.4% | Miss | +9.8% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for CRSP
See the fair value, the probability range and the earnings history of CRISPR Therapeutics AG on its ATLAS page.
CRISPR Therapeutics AG (CRSP) stock analysisPlans from €3.99 a month.
CRISPR Therapeutics AG earnings: frequently asked questions
When does CRISPR Therapeutics AG (CRSP) report earnings?
CRISPR Therapeutics AG is scheduled to report on Monday, November 9, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for CRSP?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$1.06 per share (USD). Estimates can change before the report.
How often does CRSP beat earnings estimates?
Of its last 4 reports with a recorded result, CRISPR Therapeutics AG beat the EPS estimate 2 times; the average surprise was +34.2%. Past results do not predict the next one.
How much does CRSP move around earnings?
Over its last 4 reports the stock moved an average of 3.6% (absolute, from the close before the report day to the close after it), and finished higher 3 of 4 times.
Did CRISPR Therapeutics AG beat earnings estimates last quarter?
CRISPR Therapeutics AG last reported on Jul 28, 2026: EPS of $0.89 against an estimate of $0.87 (+2.3% surprise), a beat.
How much does CRSP usually move in a day?
On a normal trading day the ATLAS model puts CRSP’s one-day range at about ±3.2%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 9, 2026
Educational information, not investment advice. Disclaimer